In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $1.67 in the prior trading day, Citius Oncology Inc. (NASDAQ: CTOR) closed at $1.60, down -4.19%. In other words, the price has decreased by -$4.19 from its previous closing price. On the day, 0.68 million shares were traded. CTOR stock price reached its highest trading level at $1.6483 during the session, while it also had its lowest trading level at $1.51.
Ratios:
Our goal is to gain a better understanding of CTOR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.01 and its Current Ratio is at 0.01. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTOR now has a Market Capitalization of 114086400. As of this moment, Citius’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.54.
Stock Price History:
Over the past 52 weeks, CTOR has reached a high of $49.00, while it has fallen to a 52-week low of $1.53. The 50-Day Moving Average of the stock is -79.66%, while the 200-Day Moving Average is calculated to be -84.22%.
Shares Statistics:
The stock has traded on average 203.57K shares per day over the past 3-months and 128800 shares per day over the last 10 days, according to various share statistics. A total of 2.34M shares are outstanding, with a floating share count of 0.35M. Insiders hold about 97.47% of the company’s shares, while institutions hold 25.44% stake in the company.
